Diagnosis and detection of breast cancer and other cancers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 6, 2001
Grant Date -
N/A
app pub date -
Jan 20, 1999
filing date -
Jan 22, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Measurements of elevated levels of riboflavin carrier protein (RCP) can be used to detect breast, liver, ovarian, and endometrial cancers. Stains for riboflavin carrier protein can be used to visualize malignancies in tissue specimens. The new technique is particularly well-suited for the early detection of breast cancer. With a radioimmunoassay for RCP, we have observed that serum RCP levels were significantly elevated in women with breast cancer as compared to control subjects. A serum RCP level .gtoreq.1.0 ng/ml was highly predictive of the presence of breast cancer (other than in pregnant females).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully